baber/WOPTO huggingface dataset:
Patent CA-3135793-A1 (CA)
Title: Systeme de traitement de batterie intelligent externe a activation vocale
Inventor: DELORENZO ANDREW ANGELO
IPC: G06F1/16
Filed: 2020-04-01
Abstract: L'invention concerne un système de batterie intelligent (100). Le système de batterie intelligent (100) comprend un système externe (104) possédant au moins un capteur (202) doté d'un microphone qui est configuré pour identifier un signal audio d'entrée. Un processeur (200) est configuré pour traiter le signal audio d'entrée et lancer une session d'assistant vocal pour un dispositif hôte (102) en mode de fonctionnement en veille ou hors tension. Le dispositif hôte (102) est apparié au système externe. Une batterie (204) est conçue pour alimenter le processeur (200) et le dispositif hôte (102), et un haut-parleur (206) fournit une rétroaction à partir du dispositif hôte (102) en réponse au signal audio d'entrée.
Patent CA-3136753-A1 (CA)
Title: Substituted 1-oxo-isoindoline-5-carboxamide compounds, compositions thereof, and methods of treatment therewith
Inventor: BACULI FRANS
IPC: C07D401/14
Filed: 2020-05-29
Abstract: Provided herein are 1-oxo-isoindoline-5-carboxamide compounds having the following structure of Formula (I), wherein R<sup>1</sup>, R<sup>2</sup>, R<sup>3</sup>, R<sup>4</sup> and n are as defined herein, compositions comprising an effective amount of a 1-oxo-isoindoline-5-carboxamide compound, and methods for treating or preventing disorders.
Patent CA-3137913-A1 (CA)
Title: Method for selectively accepting phone calls and text messages
Inventor: CLAY GEORGE FORSYTHE
IPC: H04M3/436
Filed: 2020-04-29
Abstract: In a method for selectively authorizing calls and text messages, it is determined if an identification code, such as CallerID or phone number, included with a call or text from a remote phone is also included in a table or list of identification codes accessible to a user phone. In the event of no match, a user notification means of the user phone is not activated and a prompt is sent to the remote phone requesting entry of a passcode into the remote phone. Upon receipt of the passcode entered into remote phone at the user phone, it is determined if the received passcode is also included in a table or list of passcodes accessible to a user phone. In the event of a match, the user notification means of the user phone is activated. Otherwise, the user notification means of the user phone is not activated.
Patent CA-3139392-A1 (CA)
Title: User terminal and radio communication method
Inventor: MATSUMURA YUKI
IPC: H04W16/28
Filed: 2019-05-10
Abstract: A user terminal according to one embodiment of the present invention comprises: a control unit that, on the basis of at least one of reported ability information and a downlink control information (DCI) format for scheduling specific uplink transmission, uses a quasi-collocation (QCL) for specific downlink transmission or a reference signal relating to a spatial relationship for uplink transmission satisfying a predetermined condition in the spatial relationship of the specific uplink transmission; and a transmission unit that performs the uplink transmission in accordance with the spatial relationship of the specific uplink transmission. One embodiment of the present invention makes it possible to suitably control a UL beam.
Patent CA-3144873-A1 (CA)
Title: Carbon dioxide capture, products incorporating or produced using captured carbon dioxide, and economic benefits associated with such products
Inventor: BROWN JR GLENN WILLIAM
IPC: B01D53/62
Filed: 2020-06-26
Abstract: The present disclosure provides methods whereby products can be prepared in a manner that adds value to the products beyond the market value of such products, and the present disclosure further provides methods for optimizing production of products toward processes that yield a positive net result. The methods for preparing a product can utilize a synthesized oxide compound and, depending upon the order of combination, can modify the synthesized oxide compound by combination with both of carbon dioxide and a secondary component.
Patent CA-3147089-A1 (CA)
Title: Sowing device and method for treating seeds during planting
Inventor: RICKARD JAMIE
IPC: A01C7/06
Filed: 2020-08-14
Abstract: The present invention relates to a sowing device for discharging and treating discharched plant propagation materials during their fall onto an underlying agricultural surface (B), having a reservoir container (10) for the plant materials, having a separating device (20) which is configured to separate plant materials (K) fed from the reservoir container and to output them individually, and having an application device (30) to apply a dressing comprising a substrate bearing at least one agricultural compound onto the separated plant materials from a cartridge assembly comprising one or more cartridges that each are separate from the reservoir container in the sowing device, wherein the application device is configured to apply the dressing from the one or more cartridges to the separated plant materials after they leave the separating device while the separated plant materials fall freely on toward the underlying agricultural surface wherein the device and the one or more cartridges are configured to allow repeated removal from the device, and optionally, refilling with the dressing composition and replacing in the device, with minimal operator interaction.
Patent CA-3148536-A1 (CA)
Inventor: SHELTON ANNE PERNILLE TOFTENG
IPC: A61K38/00
Filed: 2020-08-26
Abstract: Compstatin analogues having improved binding and complement-inhibiting activity as compared to the 13 amino acid compstatin peptide (ICWQDWGHHRCT (cyclic C2-C12)) are described, in particular compstatin analogues that additionally possess useful physicochemical properties. The analogues have a thioether bond rather than a disulfide bond between the side chains of the residues corresponding to cysteines 2 and 12 of compstatin which may increase stability. The analogues may also have an isoleucine residue at position 3 in place of the wild type valine residue, which provides compstatin peptides with improved binding and complement-inhibiting activity and also enables the introduction of other modifications, for example modifications that are capable of increasing solubility, such as the introduction of charged or polar amino acids at position 9 and/or the introduction of N- and/or C-terminal sequences.
Patent CA-3149615-A1 (CA)
Title: Systemes et procedes de creation de documents ameliores pour analyse syntaxique automatisee parfaite
Inventor: FREUNDLICH JAMES
IPC: H04L9/32
Filed: 2021-03-05
Abstract: Les systèmes de création et d'analyse syntaxique de documents améliorés de l'invention traitent des documents améliorés qui permettent la présentation de contenu de document d'une manière visuelle préférée, tout en assurant que le contenu du document puisse être capturé avec précision par un analyseur syntaxique automatisé sans que rien ne soit rejeté ou mal représenté. Le système de création de document amélioré peut créer un document amélioré en encodant du contenu de document conformément à un schéma défini, en chiffrant facultativement les données structurées résultantes en une chaîne d'octets chiffrée, et en incorporant la chaîne d'octets chiffrée sous la forme de métadonnées non visibles dans un document restitué. Le document amélioré résultant peut être analysé complètement et avec précision par un système d'analyse syntaxique de document amélioré qui est capable d'extraire, de déchiffrer et de décoder les métadonnées de document incorporées.
Patent CA-3149853-A1 (CA)
Inventor: BOYD-KIRKUP JEROME DOUGLAS
IPC: A61K39/395
Filed: 2020-09-10
Abstract: L'invention concerne des méthodes de traitement ou de prévention du cancer chez un sujet, le cancer comprenant des cellules ayant une mutation conduisant à une expression accrue d'un ligand pour HER3, la méthode comprenant l'administration d'une quantité efficace sur le plan thérapeutique ou prophylactique d'une molécule de liaison à l'antigène qui est capable de se lier à HER3 du sujet.
Patent CA-3150206-A1 (CA)
Title: Aquatic remediation system
Inventor: HERRING RODNEY
IPC: B03C5/00
Filed: 2022-02-25
Abstract: An aquatic remediation system is provided, for use in cleaning bodies of water and removing plastic waste, the aquatic remediation system comprising: a boom which includes a first end, a second end, a wall defining a bore therebetween and a plurality of apertures in the wall in fluid communication with the bore; an inlet in fluid communication with the bore; at least one releasable closure on the inlet; at least one frame extending a substantial length of the boom, attached to the boom and extending therefrom; at least one weight attached to the frame or integral with the frame; and at least one functionalized fiberglass sheet which is activated with low iron oxide, iron-doped titanium dioxide and which is retained in the frame.
Patent CA-3151975-A1 (CA)
Inventor: THORNE STEPHEN H
IPC: C12N15/39
Filed: 2020-10-16
Abstract: La présente invention concerne un poxvirus oncolytique modifié, tel qu'un virus de la vaccine, qui peut contenir des modifications dans le génome viral qui augmente la production d'une forme enveloppée extracellulaire du virus. Le poxvirus oncolytique modifié peut être utilisé comme vecteur pour une administration systémique. L'invention concerne également des procédés d'utilisation du poxvirus oncolytique modifié.
Patent CA-3153112-A1 (CA)
Inventor: NILSSON ANDERS
IPC: E04F15/02
Filed: 2020-09-23
Abstract: A set of panels including first and second panels (1, 2). The first and second panels respectively include first and second edges. The first edge includes a locking strip (19) with a locking element (5) configured to cooperate with a locking groove (4) at the second edge for locking the first edge (17) to the second edge (18). The locking element (5) includes a first locking surface (31) at a first angle (101) from a plane parallel to the first panel surface (15) and the locking groove includes a second locking surface (32) at a second angle (102) from a plane parallel to the third panel surface (13). The first angle (101) is different from the second angle (102) such that the first locking surface (31) converges towards the second locking surface (32) at a cooperation part (104) in a locked position. The first locking surface (31) cooperates with the second locking surface (32) at the cooperation part (104).
Patent CA-3153993-A1 (CA)
Inventor: BRUNEAU SAMUEL
IPC: B60L58/27
Filed: 2020-11-06
Abstract: One example provides a thermal management system for an electric vehicle including a pump to pump a thermal transfer fluid through a number of circulation loops, an electric heater to heat the thermal transfer fluid, a heat exchanger to expel heat from the thermal transfer fluid, a number of valves, and a number of fluid pathways fluidically interconnecting the pump, heater, heat exchanger and valves. The valves being controllable to a number of different positions to form the number of circulation loops, the number of circulation loops including a battery heating circulation loop extending through the heater for heating a battery pack of the vehicle, a secondary components cooling circulation loop extending through the heat exchanger to cool secondary components of the vehicle, including a motor and a motor controller, and a battery cooling circulation loop extending through the heat exchanger to cool the battery pack.
Patent CA-3154949-A1 (CA)
Title: Composition d'excipient co-traite effervescent stable et son procede de preparation
Inventor: DESAI MAHESH
IPC: A61K9/00
Filed: 2020-10-13
Abstract: L'invention concerne une composition d'excipient co-traité effervescent stable sèche comprenant : (i) d'environ 0,1 à environ 50 % en poids d'une ou plusieurs bases de type carbonate choisies dans le groupe constitué par un carbonate alcalin, un bicarbonate alcalin, un carbonate alcalino-terreux, un bicarbonate alcalino-terreux et leurs mélanges ; (ii) d'environ 0,1 à environ 50 % en poids d'un alcool de sucre de type glucide hydrosoluble et ; (iii) d'environ 0,001 à environ 40 % en poids d'un ou plusieurs acides organiques. L'invention concerne également un procédé de préparation de la composition.
Patent CA-3155735-A1 (CA)
Inventor: HINCKLEY BROOK
IPC: C22C38/12
Filed: 2020-11-06
Abstract: The present invention relates to a manganese steel alloy having a heat-treated microstructure comprising: (a) an alloy composition of: manganese: 12 to 30 wt%; carbon:1.0 to 2.0 wt%; chromium: 4.5 to 7.0 wt%; molybdenum: 0.0 to 3.0 wt%; and iron and impurities: balance, and (b) an austenitic ferrous matrix; and (c) formed refractory particles dispersed throughout the austenitic ferrous matrix such that ? 10% of the formed refractory particles are located within crystallites of the austenitic ferrous matrix, as opposed to being located at grain boundaries between the crystallites, wherein the formed refractory particles are compounds of carbides and/or borides and/or nitrides of any one or more of chromium, zirconium, hafnium, tantalum, molybdenum, and tungsten. The invention further relates to equipment adapted for high-stress gouging abrasion that includes the manganese steel alloy of the invention, and a method of producing the manganese steel alloy of the invention.
Patent CA-3156215-A1 (CA)
Inventor: MIHALI RAUL
IPC: G09G3/34
Filed: 2020-10-30
Abstract: L'invention concerne divers modes de réalisation d'un dispositif d'affichage à champ lumineux, un procédé de rendu de pixels ajusté et un support lisible par ordinateur associé, ainsi qu'un système et un procédé de correction de la vision l'utilisant. Dans un mode de réalisation, un procédé mis en oeuvre par ordinateur est prévu pour ajuster automatiquement la perception par l'utilisateur d'une image d'entrée à rendre sur un affichage numérique par l'intermédiaire d'un ensemble de pixels de celui-ci, l'affichage numérique ayant un réseau d'éléments de mise en forme de champ lumineux.
Patent CA-3156982-A1 (CA)
Inventor: GIORDANETTO FABRIZIO
IPC: A61K45/06
Filed: 2020-10-06
Abstract: A compound of Formula (I) or a pharmaceutically acceptable salt thereof is described, wherein the substituents are as defined herein. Pharmaceutical compositions comprising the same and method of using the same are also described.
Patent CA-3157622-A1 (CA)
Inventor: ZHONG HENG
IPC: C12N5/10
Filed: 2020-11-24
Abstract: The disclosure relates to methods of transformation and related compositions. In some aspects, the methods comprise wounding at least part of a region of an embryo axis comprising an epicotyl, a shoot apical meristem, and cotyledonary node, or the corresponding region in a monocot embryo axis, to produce a wounded explant, and contacting the wounded explant with a heterologous polynucleotide. In some aspects, the methods further comprise on or more selection steps which may be done in planta.
Patent CA-3157630-A1 (CA)
Inventor: FARKAS ALEXANDER T
IPC: H02J50/70
Filed: 2020-11-06
Abstract: A wireless charging system concurrently charges several wireless devices within a shielded chamber acting as a hollow electromagnetic waveguide. Electrically conductive walls of the chamber create transverse modes that support longitudinal propagation of the electromagnetic field along the waveguide with no diminution of the energy flux density due to the inverse-square law. A  transmitting antenna located inside the chamber emits an electromagnetic field that excites one or more transverse modes of the waveguide. An absorptive lid absorbs the electromagnetic field to minimize reflections that could excite longitudinal modes. Each wireless device includes a whisker antenna that receives part of the electromagnetic field for charging a battery. Due to the spatial uniformity of the electrornagnetic field, the wireless devices charge with high efficiency regardless of their positions, ensuring they all charge at a similar rate.
Patent CA-3158145-A1 (CA)
Inventor: BRANDENBURG BOERRIES
IPC: C07K14/11
Filed: 2020-10-15
Abstract: Provided herein are isolated mutant influenza hemagglutinin polypeptides, methods for providing isolated mutant hemagglutinin polypeptides, compositions comprising the same, vaccines comprising the same and methods of their use, in particular in the detection, prevention and/or treatment of influenza.
Patent CA-3158431-A1 (CA)
Inventor: PRITCHETT JAMES
IPC: H04N7/18
Filed: 2020-10-26
Abstract: Disclosed herein are devices and systems for securely housing and mounting video doorbells. In one aspect, a disclosed device encompasses a housing for securely containing the video doorbell; and a bracket assembly configured to removably mount to a dimensional object, the bracket assembly including a first bracket portion configured to releasably attach to the housing, and a second bracket portion configured to detachably couple with the first bracket portion, the second bracket portion including a mounting plate, a back plate, at least one bracket member extending from a first edge of said mounting bracket to a first edge of said back plate, and at least one tongue extending from a second edge of said mounting plate. Also disclosed herein are kits and methods for using the disclosed devices and systems.
Patent CA-3159217-A1 (CA)
Inventor: YASUDA SATOSHI
IPC: H02B1/28
Filed: 2019-11-13
Abstract: Le problème décrit par la présente invention est de faire démarrer et fonctionner en toute sécurité un dispositif électrique stocké dans une chambre électrique répartie positionnée dans une zone dangereuse. La solution selon l'invention porte sur un module d'installation industrielle 2 comprenant : un groupe de dispositifs d'installation industrielle 6 constituant une installation industrielle ; une chambre électrique répartie 5 qui est disposée dans une zone dangereuse 31 définie sur la base de la présence d'un gaz combustible et qui stocke un dispositif d'alimentation électrique qui fournit de l'énergie électrique au groupe de dispositifs d'installation industrielle 6 ; un squelette 21 qui supporte le groupe de dispositifs d'installation industrielle 6 et la chambre électrique répartie 5 ; et un dispositif d'alimentation en air externe 64 qui a une spécification antidéflagrante, qui est placé sur la chambre électrique répartie 5, et qui fournit de l'air externe à la chambre, de l'énergie électrique étant fournie au dispositif d'alimentation en air externe 64 depuis une zone non dangereuse.
Patent CA-3164395-A1 (CA)
Inventor: LINKE LYNDSEY M
IPC: C12N15/11
Filed: 2021-01-11
Abstract: Système bactérien pour la production et l'acheminement d'ARNm traduisible par un organisme eucaryote à des cellules eucaryotes Le système utilise des bactéries non pathogènes invasives pour produire et acheminer une cargaison d'ARNm fonctionnel à des cellules eucaryotes. De plus, le système utilise des bactéries pour produire un ARNm fonctionnel pouvant être extrait de la cellule bactérienne pour des applications en aval. Les bactéries contiennent au moins une cassette d'expression procaryote codant pour l'ARNm ; l'ARNm contient une séquence poly-A transcrite par voie bactérienne, et une coiffe 5' ou pseudo-coiffe, par exemple un élément de site d'entrée de ribosome interne (IRES), servant à médier la traduction dans la cellule hôte eucaryote. Des exemples de fonction d'ARNm thérapeutique comprennent, mais ne sont pas limités à, la fourniture d'un matériel génétique codant pour des anticorps, des antigènes de vaccin et des gènes défectueux dans l'hôte.
Patent CA-3165586-A1 (CA)
Title: Methods and compositions for treating and preventing viral infection
Inventor: HAN JANG HYUN
IPC: C12N15/79
Filed: 2021-01-23
Abstract: The disclosure provides recombinant polypeptides for treating or preventing viral infection comprising an immunoglobulin Fc fragment and at least one viral receptor or fragment thereof. Also provided are RNA molecules, therapeutic compositions, and expression systems comprising such recombinant polypeptides, along with methods of preventing or treating a viral infection in a subject in need thereof, comprising administering such recombinant polypeptides to a subject or patient.
Patent CA-3166573-A1 (CA)
Title: Utilisations therapeutiques de dulaglutide
Inventor: GERSTEIN HERTZEL CHAIM
IPC: A61K38/16
Filed: 2021-01-22
Abstract: La présente invention concerne des méthodes de traitement, de prévention ou de retardement de troubles liés à la cognition, tels que le déclin cognitif, la déficience cognitive ou la démence chez un patient. Spécifiquement, le procédé comprend l'administration de dulaglutide dans une quantité thérapeutiquement efficace au patient une fois par semaine. L'invention concerne en outre des procédés pour améliorer la régulation glycémique chez un patient atteint du diabète sucré de type 2, comprenant l'administration de dulaglutide dans une quantité thérapeutiquement efficace pour réduire le risque du patient subissant un déclin cognitif.
Patent CA-3167565-A1 (CA)
Title: Integrated blender and friction reducer system
Inventor: Sharp Brian
IPC: B01F35/71
Filed: 2022-07-13
Abstract: An integrated blender system includes a skid. The integrated blender system includes a blender assembly, including a blender tub including an outlet, a supply pipe coupled between a suction pump and the blender tub, and an outlet pipe coupled to the outlet of the blender tub. The integrated blender assembly includes a dry product additive system. The dry product additive system includes a skid, a hopper, a pickup funnel, a feeder system, a supply pump, and an eductor assembly. The feeder system may be configured to transport product from the hopper to the pickup funnel. The eductor assembly including a suction inlet, a motive inlet, and an outlet. The suction inlet may be coupled to the pickup funnel by a suction hose. The motive inlet may be coupled to the supply pump by a motive fluid hose. The outlet nozzle is positioned to eject fluid and product into the blender tub.
Patent CA-3170507-A1 (CA)
Title: Use of a soluble guanylate cyclase (sgc) stimulator or of a combination of a sgc stimulator and an sgc activator for conditions wherein the heme group of sgc is oxidized or wherein sgc is deficient in heme
Inventor: SCHMIDT HARALD HORST HEINZ WILHELM
IPC: A61P9/00
Filed: 2021-02-18
Abstract: The invention relates to a pharmaceutical composition comprising one or more stimulators of soluble guanylate cyclase (sGC), or a combination of at least one stimulator of sGC and at least one activator of sGC, for use in a method of treatment of a disease and/or a disorder that is/are associated with a deficiency of cyclic 3',5'-guanosine monophosphate in the patient to be treated. The invention also relates to a therapeutic combination comprising a first unit dose comprising an sGC stimulator and a second unit dose comprising an sGC activator. The invention also relates to a therapeutic combination comprising a first unit dose comprising a first sGC stimulator and a second unit dose comprising a second sGC stimulator, for use in a method for the treatment of a disease and/or a disorder that is/are associated with a deficiency of cyclic 3',5'-guanosine monophosphate in the patient to be treated. Furthermore, the invention relates to a kit comprising a pharmaceutical composition comprising one or more stimulators of sGC; a pharmaceutical composition comprising one or more stimulators of sGC and one or more activators of sGC; a therapeutic combination comprising a first unit dose comprising a first sGC stimulator and a second unit dose comprising a second sGC stimulator; or to a therapeutic combination comprising a first unit dose comprising an sGC stimulator and a second unit dose comprising an sGC activator.
Patent CA-3171322-A1 (CA)
Inventor: YAMADA KENICHI
IPC: A61P43/00
Filed: 2021-02-12
Abstract: Provided is a compound having well-balanced LO· scavenging ability and LOO· scavenging ability. A compound according to the present invention or a salt thereof is represented by formula (1). In formula (1), R1 and R2 may be the same or different and each independently represents a hydrogen atom or an alkyl group; R3 represents -OR4 or -NHR5; R4 represents a sec-butyl group, a tert-butyl group, or an iso-butyl group; and R5 represents a sec-butyl group, a tert-butyl group, or an iso-butyl group.